| General Information |
| Business: |
Note: Living Homeopathy International (LHI Proposed) withdrew its plans for an IPO in a letter to the SEC on Aug. 18, 2026. The Hong Kong-based company had filed its F-1 for its IPO in late May 2025.
(Incorporated in the Cayman Islands)
We offer homeopathic products in Hong Kong.
(Note: Living Homeopathy International withdrew its plans for its IPO in a letter to the U.S. Securities and Exchange Commission on Aug. 18, 2026. Background: Living Homeopathy International filed an F-1/a in March 2026 to disclose the terms for its IPO – 3.75 million shares at a price range of $4.00 to $6.00 to raise $19 million, if priced at the $5.00 mid-point of its range. Initial Filing: Living Homeopathy International filed its F-1 for its IPO in May 2025.)
|
| Industry: |
HOMEOPATHIC PRODUCTS |
| Employees: |
|
| Founded: |
1994 |
| Contact Information |
| Address |
Hong Kong |
| Phone Number |
|
| Web Address |
|
| View Prospectus: |
Living Homeopathy (Withdrawn) |
| Financial Information |
| Market Cap |
|
| Revenues |
$ mil (last 12 months) |
| Net Income |
$ mil (last 12 months) |
| IPO Profile |
| Symbol |
LHI |
| Exchange |
NASDAQ |
| Shares (millions): |
3.8 |
| Price range |
$4.00 - $6.00 |
| Est. $ Volume |
$19.0 mil |
| Manager / Joint Managers |
Revere Securities |
| CO-Managers |
|
| Expected To Trade: |
|
|
Status:
|
Withdrawn |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |